MannKind Corporation Reports 2015 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
MannKind (MNKD) Appoints New Chief Medical Officer
August 10, 2015 9:16 AM EDTMannKind (NASDAQ: MNKD) announced the appointment of Dr. Raymond Urbanski as its Chief Medical Officer. As Chief Medical Officer, Dr. Urbanski will lead MannKind's overall drug development activities and will be a member of the Executive Leadership Team.
"Dr.... More
MannKind (MNKD) Tops Q2 EPS by 1c
August 10, 2015 8:01 AM EDTMannKind (NASDAQ: MNKD) reported Q2 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08).
Cash and cash equivalents were $107.2 million at June 30, 2015, compared to $120.8 million in the first quarter of 2015. During the second quarter of 2015, we received $6.7 million in proceeds from warrant and option... More
